ADORA2A and melanoma: ,10,11,44 Yet, for melanoma and bladder cancer it has been observed that T cell-specific loss of A2AR adenosine receptors leads to a reduction in tumor-associated CD8+ T cells, indicating that adenosine does not interfere with T cell recruitment in solid tumors.45